Log In
Print
BCIQ
Print
Print this Print this
 

Xience Xpedition Everolimus Eluting Coronary Stent System

Also known as: Xience Xpedition

  Manage Alerts
Collapse Summary General Information
Company Abbott Laboratories
DescriptionEverolimus-eluting coronary stent system
Molecular Target Mammalian target of rapamycin (mTOR) (FRAP) (RAFT1)
Mechanism of Action 
Therapeutic ModalityMedical Devices: Drug/device combination
Latest Stage of DevelopmentMarketed
Standard IndicationCoronary artery disease (CAD)
Indication DetailsTreat coronary artery disease (CAD)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today